| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Goldberg Mark Alan is a Director at CRESCENT BIOPHARMA, INC.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $439K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2016 | CBIO Crescent Biopharma, Inc. | Director | Buy | 10,397 | $4.77 | $49,630.08 | +945.2% |